← Back to all trials
Recruiting
NCT05719025
Markers of Neurological Damage Post Covid-19 in PLWH
Conditions: COVID-19, Hiv
Sex: All
Ages: 50 Years – N/A
Healthy volunteers: 1
Enrollment: 200
Sponsor: Scientific Institute San Raffaele
Location: Italy
Summary
Both HIV infection and Covid-19 are associated to cognitive and psychiatric impairment, like anxiety and depression.
These disturbs are well-known in HIV infection and partially characterized in Covid-19.
Eligibility Criteria
Inclusion Criteria:HIV+ COVID+: people living with HIV that get corona virus disease 19 (COVID19) diagnosed at least 9 month ago with a positive rino-pharyngeal swab (molecular or antigenic), or with compatible clinic and a positive serologic test for Sars-CoV2 before the vaccination; Age > 50 years old, no gender.HIV+ COVID-: people living with HIV that had not get COVID19.
Age>50 years; no gender.HIV- COVID+: people without HIV that get COVID19 diagnosed at least 9 month ago with a positive rino-pharyngeal swab (molecular or antigenic), or with compatible clinic and a positive serologic test for Sars-CoV2 before the vaccination; Age > 50 years old, no gender.HIV- COVID-: people without HIV that had not get COVID19 (healthy people and volunteers) Age>50 years; no gender.Exclusion Criteria:Inability to perform the neuro-cognitive or functional tests due to neurologic deficit (inability to writing, reading, understand how to perform the tests)
Source: ClinicalTrials.gov (NCT05719025). StuddyBuddy aggregates publicly available trial information.